Current Gastroenterology Reports

, Volume 8, Issue 1, pp 53–59 | Cite as

Extrahepatic manifestations of hepatitis c virus



Given the high prevalence of chronic hepatitis C virus (HCV) infection, its clinical sequelae account for a significant proportion of patients presenting to gastroenterologists and hepatologists. Whereas the hepatic manifestations of hepatitis C are well described, including hepatitis, cirrhosis, and the development of hepatocellular carcinoma, the extrahepatic manifestations, though common, are less well appreciated. Although nonspecific, fatigue and arthralgias are very common in those with chronic hepatitis C. Extrahepatic syndromes have been reported in as much as 36% of HCV patients, but the exact prevalence is not known. Patients with these syndromes can be divided into those with a high degree of association and those with a more moderate or mild association with HCV. The most prevalent extrahepatic diseases with the highest degree of association with HCV are the essential mixed cryoglobulins with skin, neurologic, renal, and rheumatologic complications. Non-cryoglobulin diseases with a less definite relationship to HCV include systemic vasculitis, splenic lymphoma, porphyria cutanea tarda, and the sicca syndromes. This article highlights the pathophysiology and clinical manifestations of these disorders.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Sene D, Limal N, Cacoub P: Hepatitis C virus-associated Extrahepatic manifestations; a review. Metabol Brain Dis 2004, 19:357–438. This is an excellent recent review of the extrahepatic manifestations of HCV.CrossRefGoogle Scholar
  2. 2.
    Bonkovsky HL, Mehta S: Hepatitis C: A review and update. J Am Acad Dermatol 2001, 44:159–182.PubMedCrossRefGoogle Scholar
  3. 3.
    Lauer GM, Walker BD: Hepatitis C virus Infection. N Engl J Med 2001, 345:41–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Agnella V, DeRosa F: Extrahepatic disease manifestations of HCV Infection: some current issues. J Hepatol 2004, 40:341–352. Good review of the extrahepatic manifestations of chronic HCV.CrossRefGoogle Scholar
  5. 5.
    Cacoub P, Ratziu V, Myers RP, et al.: Impact of treatment on extrahepatic manifestations in patients with chronic hepatitis C. J Hepatol 2002, 30:812–818. Good study on the impact of anti-HCV therapy on the extrahepatic manifestations in patients with chronic HCV.CrossRefGoogle Scholar
  6. 6.
    Willson RA: Extrahepatic manifestations of viral hepatitis. Am J Gastroenterol 1997, 92:4–17.Google Scholar
  7. 7.
    Mehta S, Levey JM, Bonkovsky HL: Extrahepatic manifestations of infection with hepatitis C virus. Clin Liver Dis 2001, 5:1–21.CrossRefGoogle Scholar
  8. 8.
    8Mayo MJ: Extrahepatic manifestations of hepatitis C infection, Southwest. Int Med Conf 2002, 325:135–148.Google Scholar
  9. 9.
    Meltzer M, Franklin BC, McClusky EK, Cooper N: Cryoglobulinemia: a clinical and laboratory study-type 2 cryoglobulins with rheumatoid factor activity. Am J Med 1966, 40:837–856.PubMedCrossRefGoogle Scholar
  10. 10.
    Johnson RJ, Willson R, Yamabe H, et al.: Renal manifestations of chronic hepatitis C virus. Kidney International 1994, 46:1255–1263.PubMedCrossRefGoogle Scholar
  11. 11.
    Frangeul AL, Musset L, Cresta P, et al.: Hepatitis C virus genotypes and subtypes in patients with hepatitis C with and without cryoglobulinemia. J Hepatol 1996, 251:427–432.CrossRefGoogle Scholar
  12. 12.
    Cacoub P, Renou C, Rosenthal E, et al.: Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine 2000, 79:47–56.PubMedCrossRefGoogle Scholar
  13. 13.
    Sterling RK, Gehr T: Renal involvement in liver disease. In Hepatology: A Practical Approach. Edited by Knawy BA, Shiffman ML, Wiesner RH: Amsterdam: Elsevier; 2004:443–453. Outstanding review on renal involvement in patients with liver disease.Google Scholar
  14. 14.
    Johonson RJ, Gretch DR, Yamabe H, et al.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. New Engl J Med 1993, 328:465–470.CrossRefGoogle Scholar
  15. 15.
    Hermine O, Lefrere F, Bronowicki JP, et al.: Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002, 347:89–94.PubMedCrossRefGoogle Scholar
  16. 16.
    Kitay-Cohen Y, Amiel A, Hilzenrat N, et al.: Bcl -2 rearrangement in patients with chronic hepatitis C with essential mixed cryoglobilinemia. Blood 2000, 96:2910–2912.PubMedGoogle Scholar
  17. 17.
    Zuckerman E, Zuckerman T, Levine AM, et al.: Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Ann Int Med 1997, 127:423–428.PubMedGoogle Scholar
  18. 18.
    Haddad J, Deny P, Munz-Gotheil C, et al.: Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C liver disease. Lancet 1992, 339:321–333.PubMedCrossRefGoogle Scholar
  19. 19.
    Loustaud-Ratti V, Riche A, Liozone E, Labrousse F, et al.:Prevalence and characteristics of Sjogren's syndrome or sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol 2201, 28:2245–2251.Google Scholar
  20. 20.
    Verban H, Carlson J, Eriksson S, et al.: Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J Int Med 1999, 245:127–132.CrossRefGoogle Scholar
  21. 21.
    Koike K, Moriye K, Ishibashi K, et al.: Sialadenitis histologically resembling Sjogren's syndrome in mice transgenic for hepatitis C virus envelop genes. Proc Natl Acad Sci U S A 1997, 94:233–236.PubMedCrossRefGoogle Scholar
  22. 22.
    Gisbert JP, Garcia-Buey L, Parjares JM, Moreno-Otero R:Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatology 2003, 39:620–627. A meta-analysis of 50 studies involving over 2000 patients, looking at the prevalence of concomitant HCV and phenotypic porphyria cutanea tarda based on geographic location and reviewing its possible etiopathogenic role.CrossRefGoogle Scholar
  23. 23.
    Dienhart PWM, Sterling RK: Management of hepatitis C virus in patients with porphyria cutanea tarda. Curr Hepatitis Rep 2005, in press. Excellent review of the clinical presentation, pathophysiology, and treatment of porphyria cutanea tarda and of chronic HCV in those with coexisting conditions.Google Scholar
  24. 24.
    Sankany RP: The management of porphyria cutanea tarda. Clin Exp Dermatol 2001, 26:225–232.CrossRefGoogle Scholar
  25. 25.
    Bonkovsky HL, Poh-Fitzpatrick M, Primstone N, et al.:Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 1998, 27:1661–1669.PubMedCrossRefGoogle Scholar
  26. 26.
    Linet MS, Gridley G, Nyren O, et al.: Primary liver cancer, other malignancies and mortality risks following porphyria: a cohort study in Denmark and Sweden. Am J Epidemiol 1999, 149:1010–1015.PubMedGoogle Scholar
  27. 27.
    Lamoril J, Andant C, Bogard et al.: Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Hepatology 1998, 27:848–852.PubMedCrossRefGoogle Scholar
  28. 28.
    Chuang TY, Brashear R, Lewis C: Porphyria cutanea tarda and hepatitis C virus: a case control study and meta-analysis of the literature. J Am Acad Dermatol 1999, 41:31–36.PubMedCrossRefGoogle Scholar
  29. 29.
    Hernandez F, Blanquer A, Linares M, Lopez A, et al.: Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 1998, 99:217–220.PubMedCrossRefGoogle Scholar
  30. 30.
    Nagamine T, Ohtuka T, Takahara K, et al.: Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996, 24:135–140.PubMedCrossRefGoogle Scholar
  31. 31.
    Arao M, Murase K, Kusakabe A, Yoshioka K, et al.: Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003, 38:355–360.PubMedCrossRefGoogle Scholar
  32. 32.
    Caronia S, Taylor K, Pagliaro L, et al.: Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 30:1059–1063.PubMedCrossRefGoogle Scholar
  33. 33.
    Antonelli A, Ferri C, Pampana A, et al.: Thyroid disorders in chronic hepatitis C. Am J Med 2004, 117:10–13.PubMedCrossRefGoogle Scholar
  34. 34.
    Frider B, Sookian S, Castano G, et al.: Lichen planus, chronic hepatitis C and interferon. Hepatology 1995, 21:1764–1765.PubMedCrossRefGoogle Scholar
  35. 35.
    Mignogna MD, Muzio LL, Favia G, et al.: Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998, 37:575–578.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Division of GastroenterologyHepatology, and Nutrition, Virginia Commonwealth University Health SystemRichmondUSA

Personalised recommendations